EMPAGLIFLOZIN (SGLT2 INHIBITOR) IN TYPE 2 DIABETES MELLITUS
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 38
Abstract
BACKGROUND To study the analysis of metabolic parameters in patients with type 2 diabetes mellitus on empagliflozin, which is a SGLT2 inhibitor. MATERIALS AND METHODS This study was a prospective study of 120 patients with uncontrolled type 2 diabetes mellitus who were admitted as outpatients in JLNMCH Hospital, Bhagalpur. This study was conducted from February 2017 to April 2017. Informed consent was taken from each patient who participated in the study and the study protocol was approved by the institutions ethics and review board. Inclusion Criteria- Patients with type 2 diabetes mellitus and HbA1c >8% meeting any one of the criteria- Patients who were on dual therapy (metformin + sulfonylurea/DPP4 inhibitor); patients who were on triple therapy (metformin + sulfonylurea + DPP4 inhibitor); patients who were on insulin and triple oral therapy (metformin + sulfonylurea + DPP4 inhibitor). Exclusion Criteria- Patients who had history of genital mycotic infections, recurrent urinary tract infections, pyelonephritis, acute illness, type 1 diabetes, pregnant or lactating women, those patients who were with an eGFR below 45. RESULTS The mean age, duration of diabetes, weight and HbA1c in the study population was 54.36 ± 0.88 years, 14.2 ± 3.6 years, 76.25 ± 2.11 kgs and 9.66 ± 0.22%, respectively. The changes in weight and HbA1c were statistically significant across all groups. In 5% of the patients, genital pruritus was reported. Mycotic genital infection was seen in none of the patients on examination. All the four groups chose to discontinue the use of empagliflozin as a result of pruritus at follow up. The baseline daily insulin dose was 42 ± 25 units, and at 4 months, it was reduced to 34 ± 20 units. At follow up, the reduction in insulin level was 19.1% when compared to baseline. CONCLUSION This study showed that there was an improvement in glycaemic control and body weight with minimal side effects when SGLT2 inhibitor was added at any stage of disease with any of the pre-existing therapeutic agents for patients who had uncontrolled T2DM.
Authors and Affiliations
Mohammed Umar Farooque, Bharat Bhushan
Keywords
Related Articles
- EP ID EP219150
- DOI 10.18410/jebmh/2017/456
- Views 77
- Downloads 0
CLINICAL SIGNIFICANCE OF ULTRASONIC PLACENTAL GRADING DURING THIRD TRIMESTER IN HYPERTENSIVE DISORDERS OF PREGNANCY AND ITS CORRELATION WITH FETAL OUTCOME
Pre-eclampsia is a common (7% of all pregnancies) disorder in which normal haemodynamic response is compromised. Pre-eclampsia is an important cause of maternal and fetal morbidity and mortality. Inspite of its relevant...
STUDY ON SPANNING EXTERNAL FIXATORS FOR PERIARTICULAR OPEN FRACTURES
BACKGROUND Open fractures which occur close to any fracture need immobilisation for the soft tissues to heal. Some open fractures are even fixed with provisional fixations to maintain the alignment of the fractures. The...
COMPARISON BETWEEN INDUCTION WITH ETOMIDATE, PROPOFOL AND THIOPENTONE TO FACILITATE i-gel (SUPRAGLOTTIC AIRWAY DEVICE) INSERTION IN ELECTIVE SHORT SURGICAL PROCEDURES
BACKGROUND An ideal induction agent provides rapid and smooth onset of action, intraoperative amnesia and analgesia and optimal surgical conditions and adequate muscle relaxation with rapid recovery. Supraglottic airway...
STUDY OF PREVALENCE OF HYPOMAGNESEMIA AND CLINICAL OUTCOME IN CRITICALLYILL-PATIENTS IN TERTIARY CARE CENTER IN ANDHRA PRADESH
BACKGROUND Magnesium is the second most prevalent intracellular cation. Hypomagnesemia is common, occurring in approximately 12% of hospitalized patients. Among ICU patients, prevalence of hypomagnesemia ranges from 11%...
STUDY OF SYMPTOMS AND SIGNS RELATED TO CARDIO-VASCULAR SYSTEM, ESPECIALLY CARDIAC MURMURS IN SEVERE ANAEMIA AND ITS REVERSIBILITY AFTER CORRECTION OF ANAEMIA
BACKGROUND Anaemia is one of the commonest clinical problems in our country. It affects various organs including heart. Clinical manifestations of anaemia referable to cardiovascular system may closely simulate symptoms...